Hematological malignancy |
11–17 |
Pulmonary; disseminated |
Neutropenia, voriconazole prophylaxis |
HSCT recipients |
1, 2–5 |
Rhinocerebral; pulmonary |
Steroid prophylaxis for GvsH disease, neutropenia, voriconazole prophylaxis |
Diabetes mellitus |
17–36 (74) |
Rhinocerebral, sinus |
Acidosis—increasing iron level acidosis and hyperglycemia—has a negative impact on neutrophil chemotaxins and phagocytic activity |
Solid organ transplantation |
(0.6) 7–13, 23 |
Pulmonary, liver, and other transplant organ |
Transplant contamination |
Deferoxamine therapy |
1–6 |
Disseminated, pulmonary |
Increasing iron level |
Burns, trauma in accident |
13–20 |
Cutaneous, even 40 % of infections are disseminated |
Disruption of skin barrier (spore inoculation) |
Malnourished patients |
3 |
Gastrointestinal |
Digestion of the fungi |
(Premature) neonates |
3–21 |
Gastrointestinal |
|